These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Gabizon A; Martin F Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957 [TBL] [Abstract][Full Text] [Related]
8. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. Gregoriadis G; Florence AT Drugs; 1993 Jan; 45(1):15-28. PubMed ID: 7680982 [TBL] [Abstract][Full Text] [Related]
9. Use of liposomes as injectable-drug delivery systems. Ostro MJ; Cullis PR Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806 [TBL] [Abstract][Full Text] [Related]
10. Trends and developments in liposome drug delivery systems. Lian T; Ho RJ J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170 [TBL] [Abstract][Full Text] [Related]
11. Liposomal vaccine delivery systems. Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904 [TBL] [Abstract][Full Text] [Related]
12. Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status. Korsholm KS; Andersen PL; Christensen D Expert Rev Vaccines; 2012 May; 11(5):561-77. PubMed ID: 22827242 [TBL] [Abstract][Full Text] [Related]
13. Liposomal adjuvants for human vaccines. Alving CR; Beck Z; Matyas GR; Rao M Expert Opin Drug Deliv; 2016 Jun; 13(6):807-16. PubMed ID: 26866300 [TBL] [Abstract][Full Text] [Related]
14. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases. Oku N Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249 [TBL] [Abstract][Full Text] [Related]
15. Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673 [TBL] [Abstract][Full Text] [Related]
16. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications. Rudokas M; Najlah M; Alhnan MA; Elhissi A Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856 [TBL] [Abstract][Full Text] [Related]
17. Liposomal drug formulations in the treatment of rheumatoid arthritis. van den Hoven JM; Van Tomme SR; Metselaar JM; Nuijen B; Beijnen JH; Storm G Mol Pharm; 2011 Aug; 8(4):1002-15. PubMed ID: 21634436 [TBL] [Abstract][Full Text] [Related]
18. Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Giddam AK; Zaman M; Skwarczynski M; Toth I Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332 [TBL] [Abstract][Full Text] [Related]
19. Liposomal Delivery Systems: Design Optimization and Current Applications. Abu Lila AS; Ishida T Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940 [TBL] [Abstract][Full Text] [Related]
20. The potential of liposomal drug delivery for the treatment of inflammatory arthritis. Vanniasinghe AS; Bender V; Manolios N Semin Arthritis Rheum; 2009 Dec; 39(3):182-96. PubMed ID: 18926560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]